[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial

The Lancet 2026

View at publisher
Authors: Thomas Walter, Henning Jann, C. Ansquer, Emmanuel Deshayes, Rocio García‐Carbonero, Alexandre Teulé, Richard P Baum, Hein J Verberne, Jarosław B. Ćwikła, Rajaventhan Srirajaskanthan, Louis de Mestier, Chiara Maria Grana
+17 more Andreas Buck, Dieter Hörsch, Marianne Pavel, Lawrence Dierickx, Michael Michael, Jonathan Strosberg, Attila Kollár, Paula Jimenez-Fonseca, Anja Rinke, Maribel Del Olmo-Garcia, Anthime Flaus, Jorge Hernando, Andreas Kluge, Monika Breuninger, Serhii Melnyk, Konstantin Zhernosekov, Jaume Capdevila
DOI: 10.1016/s0140-6736(26)00604-5
Cited by: 6
References: 26

Fields of Study & Subjects

Neuroendocrine Tumor Research Advances Lung Cancer Research Studies Radiopharmaceutical Chemistry and Applications

Publication details

Journal / source
The Lancet
Publisher
Elsevier BV
Volume
408
Issue
10551
Pages
234–247
Publication date
1 July 2026
Language
EN